Skip to main content

Test Price

2,800 AED

โœ… Home Collection Available

SDHA Gene Dilated Cardiomyopathy Type 1GG Genetic Test in UAE

Executive Summary & Core Metrics

โœ… Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next-Generation Sequencing (NGS) Processing
๐Ÿš‘ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
๐Ÿงฌ Clinical Guidance: Telephonic Post-Test Clinical Guidance & Result Interpretation by a Consultant Medical Geneticist
๐Ÿ“‹ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731

Test Overview & Methodology

This advanced genetic test provides comprehensive analysis of the SDHA gene, identifying pathogenic and likely pathogenic variants associated with Dilated Cardiomyopathy Type 1GG. This hereditary condition leads to progressive heart muscle weakening and an elevated risk of sudden cardiac death. The test is essential for definitive diagnosis, family cascade screening, and guiding prophylactic clinical interventions.

Parameter Our NGS SDHA Test Single-Gene Sanger Sequencing
Method Next-Generation Sequencing (full gene, deep intronic & CNV coverage) Capillary Sequencing (exonic regions only)
Turnaround Time 3โ€“4 Weeks 4โ€“6 Weeks
Sensitivity (SNVs/Indels) โ‰ฅ99.9% 95โ€“98%
Price (AED) 2,800 2,500

Physician Insight & Safety Protocols

Clinicianโ€™s Note โ€“ Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: Genetic cardiomyopathy testing provides life-saving clarity for patients and their families. However, results must always be correlated with a full clinical cardiology evaluation, including echocardiography and family history mapping. A positive pathogenic finding should prompt immediate family cascade screening. Do not alter or discontinue any prescribed cardiac medication without consulting your treating physician or genetic counsellor.

โš ๏ธ Medication Advisory & Clinical Guidance

Do not discontinue prescribed cardiac medication without direct consultation with your doctor. This test is a diagnostic aid, not a replacement for ongoing cardiology care.

๐Ÿ›‘ Exclusion Criteria & Emergency Indicators

  • Not suitable for patients without a clinical or familial indication of dilated cardiomyopathy or an SDHA-related syndrome.
  • Avoid blood draw during acute cardiac decompensation; clinical stabilization is required before sample collection.
  • Seek immediate emergency care if you experience: new onset chest pain, syncope (fainting), rapid palpitations, or sudden shortness of breath.
  • A positive genetic result necessitates regular cardiology follow-up and advanced cardiac imaging; it does not replace standard clinical surveillance.

Patient FAQ & Clinical Guidance

1. What is the SDHA gene and why is it tested?

The SDHA gene encodes a critical catalytic subunit of mitochondrial complex II. When mutated, it causes Dilated Cardiomyopathy Type 1GG, often accompanied by an increased risk of arrhythmias and paragangliomas. This NGS test screens for all clinically relevant pathogenic variants to enable a definitive diagnosis and structured family risk management.

2. How should I prepare for the test and sample collection?

No fasting or special diet is required. However, a mandatory pre-test genetic counselling session with a licensed geneticist is necessary to construct a detailed family pedigree and discuss the implications of potential findings. Sample collection is performed via standard peripheral venipuncture or an FTA card blood spot.

3. What happens after I receive my results?

Your Consultant Medical Geneticist and referring cardiologist will jointly review the report. Pathogenic findings will be explained in detail, along with recommended surveillance protocols (e.g., echocardiogram, cardiac MRI), preventive medication strategies, and coordination of family variant testing to protect at-risk relatives.

UAE Regulatory & Data Privacy Adherence

๐Ÿ”’ Data Privacy, Security & Regulatory Compliance

DNA Labs UAE strictly adheres to the UAEโ€™s highest standards for health data protection and medical liability:

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Ensuring robust data subject rights, consent management, and security controls for all genetic and health data.
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Guaranteeing the confidentiality, integrity, and availability of electronic health records and digital diagnostic data.
  • Federal Decree-Law No. 4 of 2016 on Medical Liability: Governing clinical safety, patient consent protocols, and professional accountability throughout the diagnostic process.
  • ISO 9001:2015 Certified Quality Management System (Certificate: INT/EGQ/2509DA/3139) for consistent laboratory excellence.

Clinical & Logistical Metadata

Test Name SDHA Gene Dilated Cardiomyopathy Type 1GG Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3โ€“4 Weeks
Sample Type / Matrix Whole Blood (Peripheral) โ€“ Standard Venipuncture or FTA Card
Methodology Used Next-Generation Sequencing (NGS) with Full Gene, Deep Intronic & CNV Coverage
ICD-10-CM Code I42.8
LOINC Code 94800-2
DHA Facility License & Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians